Ahead of its acquisition by cancer imaging company Kuva Labs, Lisata Therapeutics has regained the Chinese rights to its lead ...

Vortex Biotech Holdings Limited has announced the opening of its advanced laboratory facilities at Manchester Science Park.

Amid the expected positive clinical trial results, Legend Biotech has also reiterated plans to achieve profitability in 2026.

US pharmaceutical group Merck is in talks to buy Revolution Medicines, a cancer drugmaker with a market capitalisation of more than $20bn in what would be the latest big deal in the red-hot ...

The pharmaceutical giant had been in talks to buy the cancer drug developer in a transaction that could have valued ...

Atara Biotherapeutics in Thousand Oaks is seeking approval for a new cancer treatment. It's a life and death matter for patients and the company.

Long-term data suggest Moderna’s personalized melanoma shot provides “durable tumor control,” one analyst said. Elsewhere, ...

PRINCETON, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune ...

Immuneering has reported updated data on atebimetinib in first-line pancreatic cancer patients, linking the MEK inhibitor to 64% overall survival (OS) at 12 months. The update is the latest cut of ...

They could perhaps see sustained runs beyond this year.

Lehi, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah, September 3, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to ...

Biotech headwinds are driving double-digit revenue growth and profitability for these two mid-caps.